# Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

> **NCT02101229** · PHASE2,PHASE3 · COMPLETED · sponsor: **Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète** · enrollment: 17 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Insulin, Asp(B28)-

## Key facts

- **NCT ID:** NCT02101229
- **Lead sponsor:** Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101229, "Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02101229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*